Traduction de «T-inducer cell » (Anglais → Français) :

inducer T cell | inducer T lymphocyte | T-inducer cell

CD4 lymphocyte | CD4 T cell | CD4 T-lymphocyte | CD4+ T4 helper | CD4+ T4 lymphocyte | helper CD4 cell | helper cell | helper lymphocyte | helper T lymphocyte | helper T-cell | helper-inducer T-cell | inducer cell | inducer T-lymphocyte | T4 cell | T4 helper | T-helper cell | CD4+ [Abbr.]

CD4 T cell | T4 | CD4 cell | T4 cell | T helper-inducer cell | CD4 T lymphocyte | CD4 lymphocyte | CD4-bearing T lymphocyte | T4 lymphocyte | Leu-3 cell | OKT4 cell | OKT4 lymphocyte

suppressor T cell | suppressor T-cell | suppressive T cell | suppressive lymphocyte | suppressor T lymphocyte | suppressor lymphocyte | T-suppressor cell | T-suppressor

T-killer cell [ cytotoxic T cell | cytotoxic T lymphocyte | killer T cell ]

transmitter blocker cell [ TB cell | T-B cell ]

induced pluripotent stem cell | iPS cell | iPSC [Abbr.]

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

coefficient of induced drag | induced drag coefficient | induced drag factor

The modification of the culture conditions will induce cells to grow into specific cell types, to be later reintroduced into the patient.

Induced pluripotent stem cells have many similar properties to embryonic stem cells and research continues to make progress; however, these cells cannot yet be produced to clinical standard or be treated as natural cells.

With respect to future EU support for health research, the Commission will carefully follow scientific advances in research, notably in the field of induced pluripotent stem cell research, which have many similar properties to embryonic stem cells but cannot yet be produced to full clinical standard or be treated as natural cells, and provide support as appropriate.

EU research also allows for projects that may include a comparison of different cell types, including human embryonic stem cells and induced pluripotent stem cells, keeping all avenues of research open in the light of scientific advances.